Skip to main content
Clinical Trials/NCT05959161
NCT05959161
Not Yet Recruiting
N/A

Study on Brain Network Mechanism of Deep Brain Stimulation for Parkinson's (A Retrospective Study)

Tianjin Huanhu Hospital0 sites100 target enrollmentAugust 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Tianjin Huanhu Hospital
Enrollment
100
Primary Endpoint
motor symptom
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

As a surgical intervention, DBS can effectively relieve PD tremor, rigidity, bradykinesia and other symptoms. How to better screen patients suitable for DBS treatment and conduct reasonable preoperative and postoperative evaluation is crucial to judge the treatment effect and prognosis. The clinical symptom evaluation of PD patients can be divided into motor symptom evaluation and non-motor symptom evaluation. The motor symptoms of PD patients were evaluated by UPDRS III. The evaluation of non-motor symptoms in PD patients was mainly divided into three aspects: cognitive status, emotional status, and sleep status. Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) were used to assess the cognitive status of PD patients. The Hamilton Depression Scale (HAMD) was used to assess the patients' depression status. The Hamilton Anxiety Scale (HAMA) was used to assess the patients' anxiety status. The PD Sleep Scale 2nd version, The PD Sleep Scale 2nd version, PDSS - 2), and rem Sleep Behavior Disorder Questionnaire (sweet HK) (Rapid Eye Movement Sleep behaviors Disorder Questionnaire - Hong Kong, RBDQ - HK) to assess Sleep conditions.

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
December 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tianjin Huanhu Hospital
Responsible Party
Principal Investigator
Principal Investigator

Guangrui Zhao

Associate Professor of Neurosurgery, Huanhu Hospital, Tianjin University

Tianjin Huanhu Hospital

Eligibility Criteria

Inclusion Criteria

  • The clinical diagnosis of PD is consistent with the United Kingdom Parkinson's Disease Society Brain Bank criteria, with disease duration over 5 years, age under 75, acute levodopa motor response ≥30%, and indication for STN-DBS. -

Exclusion Criteria

  • patients with severe cognitive impairment, severe psychiatric disorders, acute levodopa motor response less than 30%, atypical parkinsonism, and contraindications to surgery -

Outcomes

Primary Outcomes

motor symptom

Time Frame: 2023.1 to 2025.12

UPDRS III score changes

Similar Trials